Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lucid, AbbVie, Playstudios, and Twitter and Encourages Investors to Contact the Firm
27 avr. 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stronghold, AbbVie, Twitter, and Li-Cycle and Encourages Investors to Contact the Firm
22 avr. 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 22, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AbbVie and Twitter and Encourages Investors to Contact the Firm
17 avr. 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 17, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages AbbVie Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – ABBV
16 avr. 2022 11h00 HE
|
The Rosen Law Firm PA
NEW YORK, April 16, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AbbVie Inc. (NYSE: ABBV) between April 30, 2021 and...
Inventiva reçoit un paiement d'étape de 4 M€ de la part d’AbbVie suite au lancement de l’étude de Phase IIb avec cedirogant
31 janv. 2022 16h00 HE
|
INVENTIVA
Daix (France), Long Island City (New York), Etats-Unis, le 31 janvier 2022 – Inventiva S.A. (« Inventiva » ou la « Société ») (Euronext Paris et Nasdaq : IVA), société biopharmaceutique spécialisée...
Inventiva receives a €4 million milestone payment from AbbVie for cedirogant Phase IIb initiation
31 janv. 2022 16h00 HE
|
INVENTIVA
Daix (France), Long Island City (New York, United States), January 31, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral...
Women In Bio Elects Dr. Azurii Collier as 2022 President-Elect
20 déc. 2021 11h47 HE
|
Women In Bio
Pittsburgh, PA, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Women In Bio (WIB), a national organization of professionals committed to promoting the careers, leadership and entrepreneurship of all women in the...
Idera Pharmaceuticals Announces Tilsotolimod Updates
14 déc. 2021 16h32 HE
|
Idera Pharmaceuticals, Inc.
EXTON, Pa., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,” “us,” and “our”) (Nasdaq: IDRA) today announced clinical updates regarding tilsotolimod, its...
Ronald McDonald House Charities (RMHC) Announces Impact of Historic Partnership with AbbVie
24 août 2021 09h00 HE
|
Ronald McDonald House Charities
Chicago, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Today, Ronald McDonald House Charities® (RMHC®) is grateful to announce the transformational impact of AbbVie’s $100 million contribution to the...
SOLITON ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of SOLY and Encourages Investors to Contact the Firm
11 mai 2021 11h33 HE
|
Bragar Eagel & Squire
NEW YORK, May 11, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of...